Latest Institutional Transactions on Impel Pharmaceuticals Inc (IMPL)
This table provides information on the latest institutional transactions involving Impel Pharmaceuticals Inc (IMPL) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 12, 2022
Q2 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-1.04KClosed |
$6.06K - $10.5K
|
0
$0
|
|
Aug 11, 2022
Q2 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-2.92KClosed |
$17K - $29.5K
|
0
$0
|
|
Aug 11, 2022
Q2 2022
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-23.7KClosed |
$138K - $240K
|
0
$0
|
|
Aug 10, 2022
Q2 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
575New |
$3.35K - $5.82K
|
575
$11.5
|
|
Aug 04, 2022
Q2 2022
|
Brighton Jones LLC
|
SELL
|
- |
-70- 0.49% |
$408 - $708
|
14.1K
$283
|
|
Aug 04, 2022
Q2 2022
|
New York State Common Retirement Fund
|
SELL
|
- |
-6.8K- 99.34% |
$39.7K - $68.8K
|
45
$0.9
|
|
Jul 25, 2022
Q2 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-27.9KClosed |
$163K - $283K
|
0
$0
|
|
Q1 2022 | |||||||
May 16, 2022
Q1 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-142KClosed |
$833K - $1.4M
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Point72 Hong Kong LTD
Hong Kong, K3 |
SELL
|
- |
-5.86KClosed |
$34.4K - $57.8K
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-800Closed |
$4.69K - $7.88K
|
0
$0
|
|
May 16, 2022
Q1 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-209KClosed |
$1.22M - $2.06M
|
0
$0
|
|
May 16, 2022
Q1 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-58.4KClosed |
$342K - $575K
|
0
$0
|
|
May 12, 2022
Q1 2022
|
Anson Funds Management LP
Dallas, TX |
SELL
|
- |
-17.7KClosed |
$104K - $175K
|
0
$0
|
|
Q4 2021 | |||||||
Feb 14, 2022
Q4 2021
|
Maven Securities LTD
St Helier, Y9 |
SELL
|
- |
-25KClosed |
$208K - $304K
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-100KClosed |
$833K - $1.21M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Ardsley Advisory Partners LP
Stamford, CT |
SELL
|
- |
-311KClosed |
$2.59M - $3.77M
|
0
$0
|
|
Feb 11, 2022
Q4 2021
|
King Wealth
Saratoga Springs, NY |
SELL
|
- |
-20KClosed |
$167K - $243K
|
0
$0
|
|
Feb 10, 2022
Q4 2021
|
Towercrest Capital Management
Newtown, PA |
SELL
|
- |
-50.5KClosed |
$421K - $613K
|
0
$0
|
|
Feb 07, 2022
Q4 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-80.4KClosed |
$670K - $976K
|
0
$0
|
|
Jan 21, 2022
Q4 2021
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-201KClosed |
$1.67M - $2.44M
|
0
$0
|
|
Jan 18, 2022
Q4 2021
|
Lindbrook Capital, LLC
|
BUY
|
- |
1.16K+ 60.84% |
$9.63K - $14K
|
3.06K
$61.1
|
|
Jan 10, 2022
Q4 2021
|
Fny Investment Advisers, LLC
|
SELL
|
- |
-5.38KClosed |
$44.8K - $65.3K
|
0
$0
|
|
Q3 2021 | |||||||
Nov 15, 2021
Q3 2021
|
Pinz Capital Management, LP
New York, NY |
SELL
|
- |
-6.19KClosed |
$51.9K - $162K
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
BUY
|
- |
333K+ 8.77% |
$2.79M - $8.71M
|
4.14M
$82.7K
|
|
Nov 15, 2021
Q3 2021
|
Zimmer Partners, LP
New York, NY |
SELL
|
- |
-25KClosed |
$210K - $653K
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-27.1KClosed |
$227K - $709K
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
139KNew |
$1.16M - $3.62M
|
139K
$2.77K
|
|
Q2 2021 | |||||||
Aug 16, 2021
Q2 2021
|
5 Am Venture Management, LLC
San Francisco, CA |
BUY
|
- |
2.88MNew |
$21.1M - $43.8M
|
2.88M
$57.7K
|
|
Aug 16, 2021
Q2 2021
|
Vivo Capital, LLC
Palo Alto, CA |
BUY
|
- |
2.88MNew |
$21.1M - $43.8M
|
2.88M
$57.7K
|
|
Aug 16, 2021
Q2 2021
|
Davidson Kempner Capital Management LP
New York, NY |
BUY
|
- |
230KNew |
$1.69M - $3.5M
|
230K
$4.6K
|
|
Aug 16, 2021
Q2 2021
|
Ven Bio Partners LLC
San Francisco, CA |
BUY
|
- |
2.76MNew |
$20.2M - $41.9M
|
2.76M
$55.2K
|